low density lipoprotein receptor adaptor protein 1
Dernière mise à jour 18 Aug 2020
Respecte les directives éditoriales
- TéléchargerTélécharger
- Partager
- Language
- Discussion
- Ask Patient
- Version audio
- Ajouter aux sources préférées sur Google
La LDLRAP1 gene (also known as ARH) provides instructions for making a protein that helps remove cholesterol from the bloodstream. Cholesterol is a waxy, fat-like substance that is produced in the body and obtained from foods that come from animals. The function of the LDLRAP1 protein is particularly important in the liver, which is the organ responsible for clearing most excess cholesterol from the body.
Sélections vidéo pour GènesBibliothèque vidéo
Normal function
La LDLRAP1 gene (also known as ARH) provides instructions for making a protein that helps remove cholesterol from the bloodstream. Cholesterol is a waxy, fat-like substance that is produced in the body and obtained from foods that come from animals. The function of the LDLRAP1 protein is particularly important in the liver, which is the organ responsible for clearing most excess cholesterol from the body.
The LDLRAP1 protein interacts with a protein called a low-density lipoprotein receptor. This type of receptor attaches (binds) to particles called low-density lipoproteins (LDLs), which are the primary carriers of cholesterol in the blood. The receptors sit on the outer surface of cells, where they pick up LDLs circulating in the bloodstream. The LDLRAP1 protein appears to play a critical role in moving these receptors, together with their attached LDLs, from the cell surface to the interior of the cell. Once inside the cell, LDLs are broken down to release cholesterol. The cholesterol is then used by the cell, stored, or removed from the body.
Conditions referring to this gene or chromosome
Other names
ARH
ARH_HUMAN
autosomal recessive hypercholesterolemia protein
FHCB1
FHCB2
LDL receptor adaptor protein
MGC34705
Related patient information and medicines

Patient information leaflet
Hypercholestérolémie familiale
Qu'est-ce que familial hypercholesterolaemia (FH). Some children m... Dr Krishna Vakharia , 13th September 2024 The National Institute for Health and Care Excellence (NICE) is recommending evinacumab alongside diet and other low-density lipoprotein-cholesterol (LDL‑C) lowering therapies as an option for treating homozygous familial hypercholesterolaemia.

Patient information leaflet
Hypercholestérolémie
Cholestérol est a fat chemical (lipid) that is made in the cells in your body. Many different cells make cholesterol but cells in the liv... Cholesterol is carried in the blood by particles called lipoproteins. When low-density lipoproteins (LDL cholesterol) carry cholesterol this is referred to as 'bad' cholesterol. Higher levels of LDL.

Patient information leaflet
Statines et autres médicaments hypolipémiants
However, national guidelines recommend that people who have not been diagnosed with cardiovascular disease, but would benefit from taking a statin to... This is a 'high-intensity' statin - the aim of giving high-intensity statins is to reduce votre low-density lipoprotein (LDL) cholesterol (sometimes called the 'bad cholesterol') by at least 40%..

Patient information leaflet
Syndrome néphrotique
Nephrotic syndrome is a condition where the 'filters' in the kidney become 'leaky' and large amounts of protein leak from the blood into the urine. The main symptom is fluid retention (oedema) which is mainly due to the low protein level in the blood. Various diseases can cause nephrotic syndrome, some more serious than others. Treatment and.

Patient information leaflet
Tests de fonction hépatique
Tests de fonction hépatique measure a series of chemicals which relate to the way the liver works. They include substances t... If the liver is swollen, through inflammation or disease, it can swell out from under the ribs and make your tummy swollen. Liver function Liver function The liver is a factory for the production and breakdown of carbohydrates,.

Patient information leaflet
néphropathie à IgA
néphropathie à IgA is a condition in which a protéines cause damage to the kidneys. The protein is called immunoglobulin A or IgA. Nephropathy means an illness that damages the kidney. The main job of the kidneys is to clear waste materials from the body and maintain a normal balance of fluids and chemicals in the body. The kidneys also have other.
Lectures complémentaires et références
- low density lipoprotein receptor adaptor protein 1; MedlinePlus, National Library of Medicine.
- Garcia CK, Wilund K, Arca M, Zuliani G, Fellin R, Maioli M, Calandra S, Bertolini S, Cossu F, Grishin N, Barnes R, Cohen JC, Hobbs HH. Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science. 2001 May 18;292(5520):1394-8. doi: 10.1126/science.1060458. Epub 2001 Apr 26.
- Garuti R, Jones C, Li WP, Michaely P, Herz J, Gerard RD, Cohen JC, Hobbs HH. The modular adaptor protein autosomal recessive hypercholesterolemia (ARH) promotes low density lipoprotein receptor clustering into clathrin-coated pits. J Biol Chem. 2005 Dec 9;280(49):40996-1004. doi: 10.1074/jbc.M509394200. Epub 2005 Sep 22.
- Michaely P, Li WP, Anderson RG, Cohen JC, Hobbs HH. The modular adaptor protein ARH is required for low density lipoprotein (LDL) binding and internalization but not for LDL receptor clustering in coated pits. J Biol Chem. 2004 Aug 6;279(32):34023-31. doi: 10.1074/jbc.M405242200. Epub 2004 May 27.
- Sirinian MI, Belleudi F, Campagna F, Ceridono M, Garofalo T, Quagliarini F, Verna R, Calandra S, Bertolini S, Sorice M, Torrisi MR, Arca M. Adaptor protein ARH is recruited to the plasma membrane by low density lipoprotein (LDL) binding and modulates endocytosis of the LDL/LDL receptor complex in hepatocytes. J Biol Chem. 2005 Nov 18;280(46):38416-23. doi: 10.1074/jbc.M504343200. Epub 2005 Aug 29.
- Soutar AK, Naoumova RP, Traub LM. Genetics, clinical phenotype, and molecular cell biology of autosomal recessive hypercholesterolemia. Arterioscler Thromb Vasc Biol. 2003 Nov 1;23(11):1963-70. doi: 10.1161/01.ATV.0000094410.66558.9A. Epub 2003 Sep 4.
- Soutar AK, Naoumova RP. Autosomal recessive hypercholesterolemia. Semin Vasc Med. 2004 Aug;4(3):241-8. doi: 10.1055/s-2004-861491.
- Wilund KR, Yi M, Campagna F, Arca M, Zuliani G, Fellin R, Ho YK, Garcia JV, Hobbs HH, Cohen JC. Molecular mechanisms of autosomal recessive hypercholesterolemia. Hum Mol Genet. 2002 Nov 15;11(24):3019-30. doi: 10.1093/hmg/11.24.3019.
Partagez vos pensées ou expériences avec les autres dans notre communautés de patients.
Inscrivez-vous à la newsletter Patient
Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.
En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.

